U.S. agencies supporting fight against HIV/AIDS in Malawi

"U.S. agencies that work to fight HIV this week began a five-year effort with Malawi's government to improve health care for Malawians infected with the virus," VOA News reports. The Elizabeth Glaser Pediatric AIDS Foundation is leading the effort alongside health officials in Malawi, with funding from PEPFAR and the CDC, the news service notes, adding, "The program -- targeting seven districts across Malawi -- aims to build on the country's success in combating HIV/AIDS." Charles Lyons, president and CEO of the Glaser Foundation, "says over the next five years, the program will ... seek to counsel one million Malawians, test and provide medical male circumcision to 50,000 adult men -- which will help avert 15,000 new infections among them and their partners -- offer HIV testing to about 400,000 pregnant women, as well as providing life-long ARV treatment for 25,000 women expected to be found positive," VOA writes (Masina, 3/29).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Llama-derived molecules target hidden strains of HIV